4//SEC Filing
Koppikar Utpal 4
Accession 0001567619-23-004538
CIK 0001604464other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:47 PM ET
Size
5.2 KB
Accession
0001567619-23-004538
Insider Transaction Report
Form 4
Koppikar Utpal
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-03-02$3.63/sh−6,871$24,921→ 181,978 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2023 and March 3, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001742696
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:47 PM ET
- Size
- 5.2 KB